the Journal of Coagulation Disorders Vol 2 Issue 1
First Attempt at Immune Tolerance Induction with Factor VIII/von Willebrand Factor Concentrates in Hemophilia A Children with High‐Titer Inhibitors
Helen Platokouki, Helen Pergantou, Anna Komitopoulou and Panagiota Xafaki
Clinical Utility of the Less Commonly Employed Assays for Lupus Anticoagulant Detection: the Evidence
W Gary Moore
Chronobiology of Vascular Disorders: a “Seasonal” Link between Arterial and Venous Thrombotic Diseases?
R Manfredini, F Manfredini, AM Malagoni, B Boari, R Salmi, F Dentali and W Ageno
Prophylaxis with Recombinant Activated Factor VII in Hemophilia Patients with Inhibitors
Günter Auerswald and Massimo Morfini
Anticoagulation of Pregnant Women with Mechanical Heart Valve Prosthesis: A Systematic Review of the Literature (2000–2009)
Ahmed Hassouna and Hemat Allam
Benefits of Fluid Therapy on the Hemostatic System of Intensive Care Patients
A Sibylle Kozek‐Langenecker
Factor VIII Inhibitor Assays: Methodology, Shortcomings, and Challenges
M van Geffen, M Dardikh and B Verbruggen
Management of Acquired Hemophilia: A Literature Review
Pål Andrè Holme and Geir Erland Tjønnfjord
Pentasaccharides: a New Class of Anticoagulants in Clinical Practice
Hikmat Abdel‐Razeq
Prevalence and Treatment of Von Willebrand Disease‐Related Menorrhagia in Adolescents: A Review
Sameh Mikhail and Peter Kouides
Clinical Perspective of Congenital Vitamin K‐Dependent Coagulation Factor Deficiency
A Amir Kuperman and Benjamin Brenner
Other Articles
- Strategies to Enable a Stable Warfarin Maintenance Dose
- Use of Human Prothrombin Complex Concentrate in Patients with Acquired Deficiency and Active or in High-Risk Severe Bleeding
- Warfarin Use and Risk of Valvular Calcification
- Genetic Testing for the Diagnosis of Von Willebrand Disease: Benefits and Limitations
- The Molecular Basis of Type 3 von Willebrand Disease
